Nuclear CMOs and CDMOs

Course overview

1. Define the role of nuclear CMOs and CDMOs in radiopharmaceutical development and production 2. Examine regulatory challenges in radiopharmaceutical manufacturing, with emphasis on 21 CFR Part 211 versus 21 CFR Part 212 NOTE: An annual subscription for Purdue's nuclear pharmacy re-certification program provides access to both the continuing education component of the program and the "Radiopharmacy Portal" a reference resource for practitioners. Subscriptions to the continuing educational offerings, which have been accredited through ACPE and BPS, can be purchased for an annual fee of $225 for nuclear pharmacists and $125 for nuclear pharmacy technicians.